Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Injection in Bruxism Based on Facial Morphology
NCT07673471Completed
- Sponsor
- Biruni University
- Start
- Feb 2026
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in bruxism, sponsored by Biruni University. Primary endpoint: Change in Center of Force at 15 days. Started Feb 2026; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
bruxism
Beyond the preview
Go deeper on NCT07673471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07673471.